Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2026-05-13 @ 8:37 AM
Study NCT ID:
NCT01324505
Status:
COMPLETED
Last Update Posted:
2017-02-08
First Post:
2011-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NN9535-3819
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None